Bristol-Myers Squibb Co - Under Terms of Agreement, Repertoire Will Receive up to $1.8 Bln for Achieving Development, Regulatory Commercial Milestones
百時美施貴寶公司——根據協議條款,Repertoire將獲得高達18億美元的收入,用於實現開發、監管商業里程碑
Bristol-Myers Squibb Co - Under Terms of Agreement, Repertoire Will Receive up to $1.8 Bln for Achieving Development, Regulatory Commercial Milestones
百時美施貴寶公司——根據協議條款,Repertoire將獲得高達18億美元的收入,用於實現開發、監管商業里程碑
使用瀏覽器的分享功能,分享給你的好友吧